Partial Loss of Psychiatric Risk Gene Mir137 in Mice Causes Repetitive Behavior and Impairs Sociability and Learning Via Increased Pde10a.
Ying Cheng,Zhi-Meng Wang,Weiqi Tan,Xiaona Wang,Yujing Li,Bing Bai,Yuxin Li,Shuang-Feng Zhang,Hai-Liang Yan,Zuo-Lun Chen,Chang-Mei Liu,Ting-Wei Mi,Shuting Xia,Zikai Zhou,An Liu,Gang-Bin Tang,Cong Liu,Zhi-Jie Dai,Ying-Ying Wang,Hong Wang,Xusheng Wang,Yunhee Kang,Li Lin,Zhenping Chen,Nina Xie,Qinmiao Sun,Wei Xie,Junmin Peng,Dahua Chen,Zhao-Qian Teng,Peng Jin
DOI: https://doi.org/10.1038/s41593-018-0261-7
IF: 25
2018-01-01
Nature Neuroscience
Abstract:Genetic analyses have linked microRNA-137 (MIR137) to neuropsychiatric disorders, including schizophrenia and autism spectrum disorder. miR-137 plays important roles in neurogenesis and neuronal maturation, but the impact of miR-137 loss-of-function in vivo remains unclear. Here we show the complete loss of miR-137 in the mouse germline knockout or nervous system knockout (cKO) leads to postnatal lethality, while heterozygous germline knockout and cKO mice remain viable. Partial loss of miR-137 in heterozygous cKO mice results in dysregulated synaptic plasticity, repetitive behavior, and impaired learning and social behavior. Transcriptomic and proteomic analyses revealed that the miR-137 mRNA target, phosphodiesterase 10a (Pde10a), is elevated in heterozygous knockout mice. Treatment with the Pde10a inhibitor papaverine or knockdown of Pde10a ameliorates the deficits observed in the heterozygous cKO mice. Collectively, our results suggest that MIR137 plays essential roles in postnatal neurodevelopment and that dysregulation of miR-137 potentially contributes to neuropsychiatric disorders in humans.